Viral Infections Clinical Trials

The Primary Objective if this study is to evaluate the efficacy of SHP640 based on clinical resolution (Defined as absence of bulbar conjunctival injection and ocular conjunctival discharge) compared with placebo in the treatment of subject with Adenoviral Conjunctivitis in the study at Visit 3(Day5).

Washington University seeks participants for a research study to look at the effects of viral/bacterial infection before or during pregnancy. There is one 30 minute study visit which includes a blood draw, stool collection and nose swab and questionnaire. Study visit will occur after 26 weeks of pregnancy. Possible risks ...

This research is being done to try to test whether a drug called Furosemide Topical Gel (CLS006) is safe and can help people with common warts. The doctor is also doing this study to compare Furosemide Topical Gel with placebo, a gel that looks like Furosemide Topical Gel but doesn’t ...

The purpose of this research study is to test the safety and effectiveness of a new investigational drug, A-101 45% Topical Solution, that is applied only to the skin. An “investigational drug” is a drug that is being tested and is not approved for use in the United States by ...

Always Hiding Your Common Warts? We want to See Them. Take the Next Step... If you or your child are 2 years of age or older, and have at least 1 common wart, you may qualify for a new research study. The study is for an investigational topical solution (applied ...

This is a clinical research trial for subjects with Viral or Bacterial Conjunctivitis (Pink Eye).  

Are you experiencing symptoms of a cold, such as a runny nose, cough, or sore throat within the last 40 hours? Act Fast! ACRC Trials is conducting a clinical trial for the common cold. The Centers for Disease Control and Prevention (CDC) reports: Common colds are the main reason that ...

Viral infections are normally controlled by T-cell immunity and are a cause of significant morbidity and mortality during the period of immune recovery after hematopoietic stem cell transplantation (HSCT). Risk for infection is impacted by the degree of tissue mismatch between donor and recipient and the immune status of the ...

Epstein-Barr virus (EBV) belongs to herpesviridae family, which infects more than 90% of the population. EBV infection is usually asymptomatic and establishes lifelong persistence in the host, although primary infection later than adolescence frequently results in infectious mononucleosis (IM). Rarely, individuals may develop a subgroup of EBV-associated life threatening complications ...

Investigators evaluated the clinical utility of Multivirus VSTs in recipients of matched related, matched unrelated, or haploidentical donor transplants. To date, 10 clinical-grade multivirus-directed VSTs have been generated from donor PBMCs. These lines were polyclonal, comprising both CD4+ (575%) and CD8+ (355%) cells and retained expression of the memory markers ...